Sunrise

company

About

We make a 3-gram sensor to diagnose sleep with gold standard quality.

  • 11 - 50

Details

Last Funding Type
Seed
Last Funding Money Raised
€6.50M
Industries
Health Care,Lifestyle,Medical Device,Wellness
Founded date
Jan 1, 2015
Number Of Employee
11 - 50
Operating Status
Active

Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.

We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate as in-lab sleep studies, at a fraction of the cost.

Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.

Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€6.50M
Sunrise has raised a total of €6.50M in funding over 2 rounds. Their latest funding was raised on Dec 15, 2021 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 15, 2021 Seed €6.50M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
Sunrise is funded by 2 investors. Fonds Vives II (University of Louvain, UCL) and Namur Invest are the most recent investors.
Investor Name Lead Investor Funding Round
Fonds Vives II (University of Louvain, UCL) Seed
Namur Invest Seed